The presentation titled “ Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: An Observational Study ” will be presented by Sonu Sahni, MD, Director of ...

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics ...

WTR is a unique and timely intelligence service informing commercial trademark decision making by assessing the business impact of trademark law developments.

Checkable Health, the company behind what could be the first FDA-authorized at-home strep test, is calling for bold regulatory reform after decades of stagnation in prescription-to-over-the-counter ...

The global point of care diagnostics market size is expected to reach USD 68.5 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science ...

A Rutgers Health review of 151 studies finds that minimizing unexplained symptoms sparks shame, trauma and avoidance of care.

A large case-control study from China found that people with Parkinson’s disease were significantly less likely to test ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

The global In Vitro Diagnostics Market is projected to be valued at USD 108.3 billion in 2024 and reach USD 150.13 billion by ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...